These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 18275123)

  • 1. [Bactericidal activity of GLL-37, a novel derivative of the human antimicrobial peptide LL-37].
    Shi L; Liu S; Fan GX; Yuan YK; Mei L
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2008 Jan; 37(1):73-7. PubMed ID: 18275123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Augmentation of the bactericidal activities of human cathelicidin CAP18/LL-37-derived antimicrobial peptides by amino acid substitutions.
    Nagaoka I; Kuwahara-Arai K; Tamura H; Hiramatsu K; Hirata M
    Inflamm Res; 2005 Feb; 54(2):66-73. PubMed ID: 15750713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic effect of antimicrobial peptide LL-37 and colistin combination against multidrug-resistant
    Morroni G; Sante LD; Simonetti O; Brescini L; Kamysz W; Kamysz E; Mingoia M; Brenciani A; Giovanetti E; Bagnarelli P; Giacometti A; Cirioni O
    Future Microbiol; 2021 Mar; 16():221-227. PubMed ID: 33646013
    [No Abstract]   [Full Text] [Related]  

  • 4. Bactericidal activity of mammalian cathelicidin-derived peptides.
    Travis SM; Anderson NN; Forsyth WR; Espiritu C; Conway BD; Greenberg EP; McCray PB; Lehrer RI; Welsh MJ; Tack BF
    Infect Immun; 2000 May; 68(5):2748-55. PubMed ID: 10768969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Azithromycin Synergizes with Cationic Antimicrobial Peptides to Exert Bactericidal and Therapeutic Activity Against Highly Multidrug-Resistant Gram-Negative Bacterial Pathogens.
    Lin L; Nonejuie P; Munguia J; Hollands A; Olson J; Dam Q; Kumaraswamy M; Rivera H; Corriden R; Rohde M; Hensler ME; Burkart MD; Pogliano J; Sakoulas G; Nizet V
    EBioMedicine; 2015 Jul; 2(7):690-8. PubMed ID: 26288841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A peptide derived from human bactericidal/permeability-increasing protein (BPI) exerts bactericidal activity against Gram-negative bacterial isolates obtained from clinical cases of bovine mastitis.
    Chockalingam A; McKinney CE; Rinaldi M; Zarlenga DS; Bannerman DD
    Vet Microbiol; 2007 Nov; 125(1-2):80-90. PubMed ID: 17560054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The C-Terminal VPRTES Tail of LL-37 Influences the Mode of Attachment to a Lipid Bilayer and Antimicrobial Activity.
    de Miguel Catalina A; Forbrig E; Kozuch J; Nehls C; Paulowski L; Gutsmann T; Hildebrandt P; Mroginski MA
    Biochemistry; 2019 May; 58(19):2447-2462. PubMed ID: 31016971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of uropathogenic Escherichia coli OmpT in the resistance against human cathelicidin LL-37.
    Brannon JR; Thomassin JL; Desloges I; Gruenheid S; Le Moual H
    FEMS Microbiol Lett; 2013 Aug; 345(1):64-71. PubMed ID: 23710656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The activity and action mechanism of novel short selective LL-37-derived anticancer peptides against clinical isolates of Escherichia coli.
    Aghazadeh H; Memariani H; Ranjbar R; Pooshang Bagheri K
    Chem Biol Drug Des; 2019 Jan; 93(1):75-83. PubMed ID: 30120878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic actions of antibacterial neutrophil defensins and cathelicidins.
    Nagaoka I; Hirota S; Yomogida S; Ohwada A; Hirata M
    Inflamm Res; 2000 Feb; 49(2):73-9. PubMed ID: 10738945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils.
    Turner J; Cho Y; Dinh NN; Waring AJ; Lehrer RI
    Antimicrob Agents Chemother; 1998 Sep; 42(9):2206-14. PubMed ID: 9736536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic Potential of Cathelicidin Peptide LL-37, an Antimicrobial Agent, in a Murine Sepsis Model.
    Nagaoka I; Tamura H; Reich J
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of the de novo engineered antimicrobial peptide WLBU2 against Pseudomonas aeruginosa in human serum and whole blood: implications for systemic applications.
    Deslouches B; Islam K; Craigo JK; Paranjape SM; Montelaro RC; Mietzner TA
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3208-16. PubMed ID: 16048927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial activity of bovine bactericidal permeability-increasing protein-derived peptides against gram-negative bacteria isolated from the milk of cows with clinical mastitis.
    Chockalingam A; Zarlenga DS; Bannerman DD
    Am J Vet Res; 2007 Nov; 68(11):1151-9. PubMed ID: 17975968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LL-37 protects rats against lethal sepsis caused by gram-negative bacteria.
    Cirioni O; Giacometti A; Ghiselli R; Bergnach C; Orlando F; Silvestri C; Mocchegiani F; Licci A; Skerlavaj B; Rocchi M; Saba V; Zanetti M; Scalise G
    Antimicrob Agents Chemother; 2006 May; 50(5):1672-9. PubMed ID: 16641434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antimicrobial effect of a novel peptide LL-1 on Escherichia coli by increasing membrane permeability.
    Zhou L; Lian K; Wang M; Jing X; Zhang Y; Cao J
    BMC Microbiol; 2022 Sep; 22(1):220. PubMed ID: 36117157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Saliva enables the antimicrobial activity of LL-37 in the presence of proteases of Porphyromonas gingivalis.
    Gutner M; Chaushu S; Balter D; Bachrach G
    Infect Immun; 2009 Dec; 77(12):5558-63. PubMed ID: 19805540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial and antibiofilm activity of LL-37 and its truncated variants against Burkholderia pseudomallei.
    Kanthawong S; Bolscher JG; Veerman EC; van Marle J; de Soet HJ; Nazmi K; Wongratanacheewin S; Taweechaisupapong S
    Int J Antimicrob Agents; 2012 Jan; 39(1):39-44. PubMed ID: 22005071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial and chemoattractant activity, lipopolysaccharide neutralization, cytotoxicity, and inhibition by serum of analogs of human cathelicidin LL-37.
    Ciornei CD; Sigurdardóttir T; Schmidtchen A; Bodelsson M
    Antimicrob Agents Chemother; 2005 Jul; 49(7):2845-50. PubMed ID: 15980359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibacterial effect of human mesenchymal stem cells is mediated in part from secretion of the antimicrobial peptide LL-37.
    Krasnodembskaya A; Song Y; Fang X; Gupta N; Serikov V; Lee JW; Matthay MA
    Stem Cells; 2010 Dec; 28(12):2229-38. PubMed ID: 20945332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.